UBS Group Reaffirms “Sell” Rating for Relx (REL)

UBS Group reiterated their sell rating on shares of Relx (LON:REL) in a report published on Friday, October 19th, investing.thisismoney.co.uk reports.

Several other brokerages also recently weighed in on REL. Deutsche Bank reissued a buy rating on shares of Relx in a research report on Friday, July 27th. Citigroup reissued a neutral rating on shares of Relx in a research report on Wednesday, July 25th. Numis Securities reissued a hold rating on shares of Relx in a research report on Thursday, July 26th. Liberum Capital reissued a buy rating on shares of Relx in a research report on Thursday, July 26th. Finally, Barclays upped their target price on shares of Relx from GBX 1,600 ($20.91) to GBX 1,615 ($21.10) and gave the company an equal weight rating in a report on Friday, July 6th. One research analyst has rated the stock with a sell rating, two have given a hold rating and ten have issued a buy rating to the company’s stock. The stock has an average rating of Buy and a consensus price target of GBX 1,780.77 ($23.27).

REL traded up GBX 27.50 ($0.36) during trading hours on Friday, hitting GBX 1,558.50 ($20.36). 4,939,419 shares of the company’s stock were exchanged, compared to its average volume of 4,990,000. Relx has a 12-month low of GBX 1,399 ($18.28) and a 12-month high of GBX 1,784 ($23.31).

About Relx

RELX PLC provides information and analytics for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals.

Recommended Story: Market Capitalization, Large-Caps, Mid-Caps, Small-Caps

Analyst Recommendations for Relx (LON:REL)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply